LONDON — An ingredient in cannabis called cannabidiol or CBD has shown promise in a clinical trial as a potential new treatment for psychosis, scientists said Friday.

In research involving 88 people with psychosis, a mental disorder characterized by anxiety, paranoia and hallucinations, the scientists found patients treated with CBD had lower levels of psychotic symptoms than those who received a placebo.

They were also more likely to be rated as improved by their psychiatrist, the study found, and there were signs of better cognitive performance and functioning.

Click here to read the complete article

Reuters via VOANews.com ~